Literature DB >> 24464124

Enhanced lentiviral vector production in 293FT cells expressing Siglec-9.

Toru Shoji1, Hiroshi Higuchi, Yoshinori Zaitsu, Ken-Ichi Nishijima, Shinji Iijima.   

Abstract

Siglecs, sialic acid-recognizing Ig-superfamily lectins, regulate various aspects of immune responses, and have also been shown to induce the endocytosis of binding materials such as anti-Siglec antibodies or sialic acid-harboring bacteria. In this study, we demonstrated that the expression of Siglec-9 enhanced the transfection efficiency of several cell lines such as macrophage RAW264 and non-hematopoietic 293FT cells. We applied this finding to the production of a lentiviral vector in which cells were transfected simultaneously with multiple vectors, and achieved a twice increase in viral production levels. Furthermore, 293FT cells expressing lectin-defective Siglec-9 produced three- to seven-fold higher titer of viral vector compared with parental 293FT cells. These results suggest that Siglec-9 enhanced lentiviral vector production in a lectin-independent manner.

Entities:  

Year:  2014        PMID: 24464124      PMCID: PMC4474984          DOI: 10.1007/s10616-013-9679-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  27 in total

1.  The sialoadhesin CD33 is a myeloid-specific inhibitory receptor.

Authors:  T Ulyanova; J Blasioli; T A Woodford-Thomas; M L Thomas
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

2.  Chicken oviduct-specific expression of transgene by a hybrid ovalbumin enhancer and the Tet expression system.

Authors:  Daisuke Kodama; Daisuke Nishimiya; Ken-Ichi Nishijima; Yuuki Okino; Yujin Inayoshi; Yasuhiro Kojima; Ken-Ichiro Ono; Makoto Motono; Katsuhide Miyake; Yoshinori Kawabe; Kenji Kyogoku; Takashi Yamashita; Masamichi Kamihira; Shinji Iijima
Journal:  J Biosci Bioeng       Date:  2011-11-11       Impact factor: 2.894

Review 3.  Siglecs--the major subfamily of I-type lectins.

Authors:  Ajit Varki; Takashi Angata
Journal:  Glycobiology       Date:  2005-07-13       Impact factor: 4.313

4.  Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes.

Authors:  A Kikuchi; S Sugaya; H Ueda; K Tanaka; Y Aramaki; T Hara; H Arima; S Tsuchiya; T Fuwa
Journal:  Biochem Biophys Res Commun       Date:  1996-10-23       Impact factor: 3.575

5.  Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.

Authors:  S P Paul; L S Taylor; E K Stansbury; D W McVicar
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

6.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

7.  Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

Authors:  Yuzuru Ikehara; Sanae Kabata Ikehara; James C Paulson
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

8.  Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.

Authors:  Gavin Nicoll; Tony Avril; Kevin Lock; Koichi Furukawa; Nicolai Bovin; Paul R Crocker
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

9.  Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin.

Authors:  P W Cheng
Journal:  Hum Gene Ther       Date:  1996-02-10       Impact factor: 5.695

10.  Integrin targeting using RGD-PEI conjugates for in vitro gene transfer.

Authors:  Klaus Kunath; Thomas Merdan; Oliver Hegener; Hanns Häberlein; Thomas Kissel
Journal:  J Gene Med       Date:  2003-07       Impact factor: 4.565

View more
  1 in total

1.  Robust Enhancement of Lentivirus Production by Promoter Activation.

Authors:  Naoto Suzuki; Takeshi Yoshida; Hiroaki Takeuchi; Ryuta Sakuma; Sayaka Sukegawa; Shoji Yamaoka
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.